Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking

Alcohol and Alcoholism

Volumn 41, Issue 4, 2006, Pages 391-398

  Iingman, Kimmo ^a   Kupila, Johanna ^a   Hyttiä, Petri ^b   Korpi, Esa R ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ARIPIPRAZOLE; DOPAMINE 2 RECEPTOR; SACCHARIN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG MEGADOSE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RETREATMENT;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; PIPERAZINES; QUINOLONES; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE D2;

ANIMALIA;

EID: 33745728832     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agl037     Document Type: Article

References (55)

1. Boileau, I., Assaad, J. M., Pihl, R. O. et al. (2003) Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 49, 226-231.
2. Bono, G., Balducci, C., Richelmi, P. et al. (1996) Dopamine partial receptor agonists reduce ethanol intake in the rat. European Journal of Pharmacology 296, 233-238.
3. Brown, E. S., Jeffress, J., Liggin, J. D. et al. (2005) Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole. Journal of Clinical Psychiatry 66, 756-760.
4. Burris, K. D., Molski, T. F., Xu, C. et al. (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. Journal of Pharmacology and Experimental Therapeutics 302, 381-389.
5. Csernansky, J. G., Wrona, C. T., Baidgett, M. E. et al. (1993) Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology (Berlin) 110, 145-151.
6. Czachowski, C. L., Santini, L. A., Legg, B. H. et al. (2002) Separate measures of ethanol seeking and drinking in the rat: Effects of remoxipride. Alcohol 28, 39-46.
7. 2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. Alcohol 10, 207-212.
8. Ericson, H., Radesäter, A. C., Servin, E. et al. (1996) Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat. Pharmacology and Toxicology 79, 277-286.
9. Files, F. J., Denning, C. E. and Samson, H. H. (1998) Effects of the atypical antipsychotic remoxipride on alcohol self-administration. Pharmacology Biochemistry and Behavior 59, 281-285.
10. Freedman, R. (2003) Schizophrenia. New England Journal of Medicine 349, 1738-1749.
11. Fujikawa, M., Nagashima, M., Inoue, T. et al. (1996) Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats. Pharmacology Biochemistry and Behavior 53, 903-909.
12. Gonzales, R. A. and Weiss, F. (1998) Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. Journal of Neuroscience 18, 10663-10671.
13. Gonzales, R. A., Job, M. O. and Doyon, W. M. (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacology and Therapeutics 103, 121-146.
14. Gründer, G., Carlsson, A. and Wong, D. F. (2003) Mechanism of new antipsychotic medications: Occupancy is not just antagonism. Archives of General Psychiatry 60, 974-977.
15. Guardia, J., Segura, L., Gonzalvo, B. et al. (2004) A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder. Alcoholism: Clinical and Experimental Research 28, 736-745.
16. Hedlund, L. and Wahlström, G. (1999) Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism. Alcoholism: Clinical and Experimental Research 23, 822-827.
17. 2 receptors in the ventral striatum and central processing of alcohol cues and craving. American Journal of Psychiatry 161, 1783-1789.
18. 18F]DMFP PET study in detoxified alcoholic patients. American Journal of Psychiatry 162, 1515-1520.
19. Honkanen, A., Ahtee, L. and Korpi, E. R. (1997) Voluntary alcohol drinking selectively accelerates dopamine release in the ventral striatum as reflected by 3-methoxytyramine levels. Brain Research 774, 207-210.
20. Hutchison, K. E., Wooden, A., Swift, R. M. et al. (2003) Olanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 28, 1882-1888.
21. Ingman, K. and Korpi, E. R. (2006) Alcohol drinking of alcohol-preferring AA rats is differentially affected by clozapine and olanzapine. European Journal of Pharmacology 535, 133-140.
22. Ingman, K., Honkanen, A., Hyytiä, P. et al. (2003) Risperidone reduces limited access alcohol drinking in alcohol-preferring rats. European Journal of Pharmacology 468, 121-127.
23. Kikuchi, T., Tottori, K., Uwahodo, Y. et al. (1995)
24. 2 receptor binding in striatal membranes of rat lines selected for differences in alcohol-related behaviours. Pharmacology and Toxicology 61, 94-97.
25. Korpi, E. R., Sinclair, J. D., Kaheinen, P. et al. (1988) Brain regional and adrenal monoamine concentrations and behavioral responses to stress in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol 5, 417-425.
26. Korpi, E. R., Päivärinta, P., Abi-Dargham, A. et al. (1992) Binding of serotonergic ligands to brain membranes of alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol 9, 369-374.
27. Lawler, C. P., Prioleau, C., Lewis, M. M. et al. (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20, 612-627.
28. Li, Z., Ichikawa, J., Dai, J. et al. (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. European Journal of Pharmacology 493, 75-83.
29. Lile, J. A., Stoops, W. W., Vansickel, A. R. et al. (2005) Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology 30, 2103-2114.
30. Linseman, M. A. (1990) Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm. Psychopharmacology (Berlin) 100, 195-200.
31. Liu, X. and Weiss, F. (2002) Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: Differences in antagonist potency in previously ethanol-dependent versus nondependent rats. Journal of Pharmacology and Experimental Therapeutics 300, 882-889.
32. 1A receptor agonist LY293284 in the drug discrimination assay in rats. Psychopharmacology (Berlin) 172, 415-421.
33. Martinez, D., Gil, R., Slifstein, M. et al. (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biological Psychiatry 58, 779-786.
34. 1A agonists: alcohol drinking in rats and squirrel monkeys. Psychopharmacology (Berlin) 167, 145-152.
35. Monnelly, E. P., Ciraulo, D. A., Knapp, C. et al. (2004) Quetiapine for treatment of alcohol dependence. Journal of Clinical Psychopharmacology 24, 532-535.
36. 2 autoreceptors in the ventral tegmental area on alcohol and saccharin intake of the alcohol-preferring P rat. Alcoholism: Clinical and Experimental Research 24, 476-483.
37. Nurmi, M., Sinclair, J. D. and Kiianmaa, K. (1998) Dopamine release during ethanol drinking in AA rats. Alcoholism: Clinical and Experimental Research 22, 1628-1633.
38. Potkin, S. G., Saba, A. R., Kujawa, M. J. et al. (2003) Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Archives of General Psychiatry 60, 681-690.
39. Potvin, S., Stip, E. and Roy, J. Y. (2003) Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: Towards testable hypotheses. International Journal of Clinical Psychopharmacology 18, 121-132.
40. Sarvihaju, M., Riikonen, J., Jaatinen, P. et al. (2004) Survival of AA and ANA rats during lifelong ethanol exposure. Alcoholism: Clinical and Experimental Research 28, 93-97.
41. Self, D. W. (2004) Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47, 242-255.
42. Semba, J., Watanabe, A., Kito, S. et al. (1995) Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology 34, 785-791.
43. Shapiro, D. A., Renock, S., Arrington, E. et al. (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28, 1400-1411.
44. Shen, R. Y. (2003) Ethanol withdrawal reduces the number of spontaneously active ventral tegmental area dopamine neurons in conscious animals. Journal of Pharmacology and Experimental Therapeutics 307, 566-572.
45. Shimokawa, Y., Akiyama, H., Kashiyama, E. et al. (2005) High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: Application to the pharmacokinctic study. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 821, 8-14.
46. Silvestre, J. S., O'Neill, M. F., Fernandez, A. G. et al. (1996) Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat. European Journal of Pharmacology 318, 257-265.
47. Sinclair, J. D., Le, A. D. and Kiianmaa, K. (1989) The AA and ANA rat lines, selected for differences in voluntary alcohol consumption. Experientia 45, 798-805.
48. Sinclair, J. D., Hyytiä, P. and Nurmi, M. (1992) The limited access paradigm: Description of one method. Alcohol 9, 441-444.
49. Soyka, M. and De Vry, J. (2000) Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence. European Neuropsychopharmacology 10, 325-332.
50. Syvälahti, E. K., Pohjalainen, T., Korpi, E. R. et al. (1994) Dopamine D2 receptor gene expression in rat lines selected for differences in voluntary alcohol consumption. Alcoholism: Clinical and Experimental Research 18, 1029-1031.
51. Warsi, M., Sattar, S. P., Bhatia, S. C. et al. (2005) Aripiprazole reduces alcohol use. Canadian Journal of Psychiatry 50, 244.
52. Weiss, F. and Porrino, L. J. (2002) Behavioral neurobiology of alcohol addiction: Recent advances and challenges. Journal of Neuroscience 22, 3332-3337.
53. Weiss, F., Mitchiner, M., Bloom, F. E. et al. (1990) Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology (Berlin) 101, 178-186.
54. Weiss, F., Lorang, M. T., Bloom, F. E. et al. (1993) Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants. Journal of Pharmacology and Experimental Therapeutics 267, 250-258.
55. Yim, H. J. and Gonzales, R. A. (2000) Ethanol-induced increases in dopamine extracellular concentration in rat nucleus accumbens are accounted for by increased release and not uptake inhibition. Alcohol 22, 107-115.